Corbus Pharmaceuticals Holdings (CRBP) Gains from Sales and Divestitures (2018)
Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Gains from Sales and Divestitures of $5.7 million in Q3 2018, up 5.75% quarter-over-quarter from $5.4 million in Q2 2018.
Corbus Pharmaceuticals Holdings (CRBP) Gains from Sales and Divestitures (2018) Analysis & Trends
Corbus Pharmaceuticals Holdings' Gains from Sales and Divestitures history runs 1 years deep, the most recent figure standing at $5.7 million for Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 135.08 Mn | 107.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 5.67 Mn |
| Sep 30, 2018 | 5.67 Mn |
| Jun 30, 2018 | 5.36 Mn |
| Jun 30, 2018 | 5.36 Mn |
| Mar 31, 2018 | 5.05 Mn |
| Mar 31, 2018 | 5.05 Mn |